Invention Grant
- Patent Title: Amino-imidazopyridine derivatives as Janus kinase inhibitors and pharmaceutical use thereof
-
Application No.: US16477249Application Date: 2018-01-10
-
Publication No.: US10703751B2Publication Date: 2020-07-07
- Inventor: Jens Larsen , Mogens Larsen , Lars Kyhn Rasmussen , Andreas Ritzen , Tine Marianne Duus
- Applicant: LEO Pharma A/S
- Applicant Address: DK Ballerup
- Assignee: Leo Pharma A/S
- Current Assignee: Leo Pharma A/S
- Current Assignee Address: DK Ballerup
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@722eb154
- International Application: PCT/EP2018/050548 WO 20180110
- International Announcement: WO2018/130563 WO 20180719
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K45/06
Abstract:
The present invention relates to a compound according to formula (I) or pharmaceutically acceptable salts, hydrates, or solvates thereof; wherein R1 is C1-alkyl, R2 is C1-alkyl, R3 is C2-alkyl, R4 is hydrogen, R5 is hydrogen. The invention relates further to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to said compounds for use in the treatment autoimmune diseases and to intermediates for the preparation of said compounds.
Public/Granted literature
- US20190367512A1 NOVEL AMINO-IMIDAZOPYRIDINE DERIVATIVES AS JANUS KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF Public/Granted day:2019-12-05
Information query
